IDH1 and astrocytoma (excluding glioblastoma): Molecular profiling differentiates IDH-wildtype grade 4 astrocytomas (known as glioblastomas) from IDH-mutant, WHO grade 4 astrocytomas, which were historically labeled as ‘secondary glioblastomas’.